Dr. Reddy's Laboratories Q3 FY25: Net Profit Rises 2% to ₹1,413 Crore, Revenue Hits ₹8,381 Crore Amid U.S. Market Challenges

Dr. Reddy's Laboratories posted a modest 2% year-on-year (YoY) increase in net profit for Q3 FY25, reaching ₹1,413 crore, up from ₹1,379 crore last year. Revenue surged by 16% to ₹8,381 crore, signaling robust overall growth. However, shares dropped by 6% following the results, driven by slower U.S. sales and heightened competition. The company continues to face pricing pressures and delayed approvals in the North American market, contributing to market concerns. To mitigate these challenges, Dr. Reddy’s is diversifying its product portfolio and expanding into emerging markets.
Source: Reuters